Use of Radiation in Extramedullary Leukemia/Chloroma: Guidelines From the International Lymphoma Radiation Oncology Group

Richard L. Bakst, Bouthaina Shbib Dabaja, Lena K. Specht, Joachim Yahalom

Research output: Contribution to journalReview articlepeer-review

16 Scopus citations

Abstract

Survival times for patients with leukemia generally have improved in recent decades, and this improvement has been attributed to an enhanced understanding of the genetics driving the cause of the disease and improved combinations of chemotherapy and targeted therapy. Durable control of systemic disease in blood and bone marrow has significantly improved survival, but extramedullary relapse can pose therapeutic challenges for which radiation therapy can have an important role. This report discusses the current role of radiation therapy for patients with leukemia, specifically the extramedullary manifestations of leukemia.

Original languageEnglish
Pages (from-to)314-319
Number of pages6
JournalInternational Journal of Radiation Oncology Biology Physics
Volume102
Issue number2
DOIs
StatePublished - 1 Oct 2018

Fingerprint

Dive into the research topics of 'Use of Radiation in Extramedullary Leukemia/Chloroma: Guidelines From the International Lymphoma Radiation Oncology Group'. Together they form a unique fingerprint.

Cite this